Benzylisochinoline muscle relaxants in clinical practice

Acta Anaesthesiologica Scandinavica, Supplement

Volumn 41, Issue 111, 1997, Pages 109-110

  Werba, A ^a   Schultz, A M ^a   Hetz, H ^a   Wiesinger, K H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; DOXACURIUM; MIVACURIUM; VECURONIUM; CISATRACURIUM; DRUG DERIVATIVE; ISOQUINOLINE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ANESTHESIA; CHOLINESTERASE BLOOD LEVEL; CONFERENCE PAPER; HUMAN; INTENSIVE CARE; MUSCLE RELAXATION; PRIORITY JOURNAL; ARTICLE; NEUROMUSCULAR BLOCKING;

ATRACURIUM; HUMANS; ISOQUINOLINES; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 0031300914     PISSN: 05152720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Basta SJ, Savarese JJ, Ali HH et al. Clinical pharmacology of doxacurium chloride, a new long acting nondepolarizing muscle relaxant. Anesthesiology 1988: 69: 478-486.
2. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U), a short-acting nondepolarising ester neuromuscular blocking drug. Anesthesiology 1988: 68: 723-732.
3. Ali HH, Savarese JJ, Embree BD et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. Br J Anaesth 1988: 61: 541-546.
4. Diefenbach C, Mellinghoff H, Lynch J, Buzello W. Mivacurium: dose-response relationship and administration by repeated injection or infusion. Anesth Analg 1992: 74: 420-423.
5. Werba A, Neiger FX, Bayer GS, Schultz AM, Maitz PKM, Wolrab C. Pharmacodynamics of mivacurium in the severely burned patient. Burns 1996: 22: 62-64.
6. Belmont MR, Lien CA, Quessy S et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995: 82: 1139-1145.
7. 2-opioid anesthesia. Anesth Analg 1996: 83: 823-829.
8. Lien CA, Belmont MR, Abalos A et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995: 82: 1131-1138.
9. Kisor DF, Schmith VD, Wargin WA et al. Importance of the organ-independent elimination of cisatracurium. Anesth Analg 1996: 83: 1065-1071.
10. Bryson HM, Faulds D. Cisatracurium besilate: A review of its pharmacology and clinical potential in anesthetic practice. Drugs 1997: 53: 848-866.